Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aiyu capsule for chemotherapy-related myelosuppression in non-small cell lung cancer
ChiCTR-IPR-15006191Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- May 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of AiYu capsule in myelosuppression and non-small cell lung cancer (NSCLC) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Blood routine tests. Planned start May 2015; status: not yet recruiting.
02
Drugs
AiYu capsule
03
Conditions
myelosuppressionnon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-IPR-15006191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006191.